Total Funding
56
58
Total FundingSeries D raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
36027
Broncus Technologies is a medical technology company developing minimally-invasive medical devices for emphysema and other lung diseases.
Henky Wibowo: ConsultantPast Role: Broncus Technologies, Vice President, Imaging and Navigation- Cary Cole: President & Chief Executive Officer
About the Company
Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatment
of homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population.
Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema.
Broncus is located in Mountain View, CA (San Francisco Bay area).
Broncus International is located in Nyon, Switzerland.
